Total Payments
$3,703
2024 Payments
$163.96
Companies
32
Transactions
112
Medicare Patients
7,476
Medicare Billing
$866,666
Payment Breakdown by Category
Food & Beverage$2,357 (63.7%)
Other$1,000.00 (27.0%)
Education$346.18 (9.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,357 | 104 | 63.7% |
| Honoraria | $1,000 | 1 | 27.0% |
| Education | $346.18 | 7 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AltaThera Pharmaceuticals LLC | $1,000 | 1 | $0 (2020) |
| Horizon Therapeutics plc | $660.95 | 30 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $479.61 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $234.62 | 8 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $170.59 | 6 | $0 (2018) |
| CALLIDITAS THERAPEUTICS US INC. | $153.68 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.88 | 1 | $0 (2022) |
| Dova Pharmaceuticals | $109.07 | 1 | $0 (2020) |
| Amgen Inc. | $90.38 | 5 | $0 (2023) |
| Paratek Pharmaceuticals, Inc. | $72.17 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163.96 | 7 | CALLIDITAS THERAPEUTICS US INC. ($61.67) |
| 2023 | $687.56 | 29 | Mallinckrodt Hospital Products Inc. ($280.26) |
| 2022 | $673.11 | 24 | Mallinckrodt Hospital Products Inc. ($147.43) |
| 2021 | $341.28 | 18 | Horizon Therapeutics plc ($181.61) |
| 2020 | $1,462 | 16 | AltaThera Pharmaceuticals LLC ($1,000) |
| 2019 | $16.77 | 1 | Amgen Inc. ($16.77) |
| 2018 | $60.96 | 4 | Relypsa, Inc. ($35.56) |
| 2017 | $297.42 | 13 | Alexion Pharmaceuticals, Inc. ($159.52) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 3 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/13/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: ANTIBIOTIC | ||||||
| 06/28/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/21/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Cardio-renal | ||||||
| 06/07/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: KRYSTEXXA | ||||||
| 02/14/2022 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Nephrology | ||||||
| 01/18/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.80 | General |
| 01/12/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: KRYSTEXXA | ||||||
| 01/11/2022 | Amgen Inc. | Tavneos (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Not Applicable | ||||||
| 01/06/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.09 | General |
| 11/17/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: KRYSTEXXA | ||||||
| 11/08/2021 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Neurology | ||||||
| 10/21/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: KRYSTEXXA | ||||||
| 10/12/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/29/2021 | Merck Sharp & Dohme Corporation | DIFICID (Drug), RECARBRIO, ZINPLAVA | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/23/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: KRYSTEXXA | ||||||
| 09/21/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Cardio-renal | ||||||
| 06/30/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: KRYSTEXXA | ||||||
| 05/27/2021 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/17/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: KRYSTEXXA | ||||||
| 05/04/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: KRYSTEXXA | ||||||
| 04/07/2021 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Oncology | ||||||
| 04/05/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: KRYSTEXXA | ||||||
| 03/23/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: KRYSTEXXA | ||||||
| 02/23/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: KRYSTEXXA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,757 | 3,133 | $381,720 | $191,539 |
| 2022 | 30 | 1,859 | 3,389 | $433,530 | $220,232 |
| 2021 | 30 | 1,921 | 3,432 | $429,155 | $219,519 |
| 2020 | 33 | 1,939 | 3,455 | $455,715 | $235,375 |
Total Patients
7,476
Total Services
13,409
Medicare Billing
$866,666
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 2 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 37 | 50 | $2,000 | $317.00 | 15.9% |
| 83721 | Ldl cholesterol level | Office | 2023 | 25 | 30 | $600.00 | $308.70 | 51.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 19 | 23 | $345.00 | $203.32 | 58.9% |
| 83735 | Magnesium level | Office | 2023 | 12 | 22 | $330.00 | $144.54 | 43.8% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 21 | 23 | $115.00 | $90.62 | 78.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 402 | 1,192 | $131,120 | $67,440 | 51.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 322 | 352 | $107,360 | $55,439 | 51.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 314 | $61,230 | $30,479 | 49.8% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 19 | 61 | $17,385 | $9,862 | 56.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 45 | 167 | $19,205 | $9,668 | 50.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 57 | 66 | $18,150 | $9,385 | 51.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 39 | 52 | $21,580 | $9,108 | 42.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 40 | 40 | $11,000 | $5,689 | 51.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 43 | 58 | $9,995 | $4,713 | 47.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 24 | 35 | $5,775 | $3,426 | 59.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $6,885 | $3,355 | 48.7% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2022 | 49 | 53 | $3,445 | $2,165 | 62.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 19 | $3,990 | $2,047 | 51.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 76 | 141 | $2,820 | $1,471 | 52.2% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 13 | 14 | $1,540 | $789.16 | 51.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 57 | 75 | $1,125 | $575.23 | 51.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 59 | 90 | $900.00 | $514.14 | 57.1% |
| 84100 | Phosphate level | Office | 2022 | 62 | 107 | $1,070 | $501.40 | 46.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 80 | 157 | $1,570 | $465.24 | 29.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 58 | 89 | $890.00 | $456.02 | 51.2% |
About Dr. Haroon Rashid, MD
Dr. Haroon Rashid, MD is a Nephrology healthcare provider based in Summerfield, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629006499.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Haroon Rashid, MD has received a total of $3,703 in payments from pharmaceutical and medical device companies, with $163.96 received in 2024. These payments were reported across 112 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,357).
As a Medicare-enrolled provider, Rashid has provided services to 7,476 Medicare beneficiaries, totaling 13,409 services with total Medicare billing of $866,666. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Summerfield, FL
- Active Since 06/29/2006
- Last Updated 03/29/2019
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1629006499
Products in Payments
- Sotalol Hydrochloride (Drug) $1,000
- KRYSTEXXA (Biological) $614.70
- ACTHAR (Biological) $479.61
- SOLIRIS (Drug) $159.52
- TARPEYO (Drug) $153.68
- JARDIANCE (Drug) $124.88
- Doptelet (Drug) $109.07
- BRILINTA (Drug) $99.99
- LOKELMA (Drug) $92.17
- NUZYRA (Drug) $72.17
- JYNARQUE (Drug) $54.93
- TEPEZZA (Drug) $46.25
- Kerendia (Drug) $42.56
- GVOKE HYPOPEN (Drug) $36.92
- Veltassa (Drug) $35.56
- DIFICID (Drug) $35.29
- ORLADEYO (Drug) $34.91
- TRULICITY (Drug) $33.40
- Kyprolis (Drug) $28.66
- GATTEX (Drug) $27.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.